Session Type
Date Time
Local Date Time

This satellite aims to move forward the dialogue on including pregnant women in HIV clinical trials. We will have a rich discussion with a panel of community leaders and will hear feedback from a series of meetings convened over the past two years by the WHO and IMPAACT focused on approaches to enhance and accelerate study of new drugs for HIV and associated infections in pregnant women. These meetings brought together women living with HIV, academic researchers, clinical experts, regulators, industry, funders, and other key stakeholders involved in studying HIV-related drugs in pregnant women, with the goal of defining how we can achieve a paradigm shift in creating timely, high-quality data about new HIV drugs used in pregnancy.

5 min
Marissa VICARI, International AIDS Society, France
10 min
Better data for ARVs in pregnancy: A multistakeholder effort
Martina PENAZZATO, World Health Organization, Switzerland
25 min
Community panel
Imelda Chipo MAHAKA, Pangaea Zimbabwe AIDS Trust, Zimbabwe
Olubukola AYINDE, Adeoyo maternity teaching hospital,, Nigeria
Polly CLAYDEN, HIV i-Base, United Kingdom
Mary NYATHI, Treatment Action Campaign, South Africa
Memory SACHIKONYE, HIV i-Base, United Kingdom
Pamela JACK FAMA, Study Participant- VESTED, Zimbabwe
Lynet MAIDZA, Study Participant- VESTED, Zimbabwe
L BALOYI, Treatment Action Campaign, South Africa
15 min
Highlights from the WHO-IMPAACT workshop on investigation of ARVs in pregnant women
Elaine ABRAMS, United States
5 min
Better and earlier pregnancy data for ARVs: A call to action
Angelina NAMIBA, 4M Network of Mentor Mothers, United Kingdom